Skip to Content
Here’s what to ask a doctor about hereditary angioedema

Hydroxyzine Pregnancy and Breastfeeding Warnings

Hydroxyzine is also known as: Atarax, Hyzine, Rezine, Vistaril, Vistazine

Hydroxyzine Pregnancy Warnings

UK: Contraindicated US: Contraindicated during early pregnancy. US FDA pregnancy category: Not Assigned Comments: This drug crosses the placental barrier, which may lead to higher fetal than maternal concentrations.

The following effects were observed immediately or only a few hours after birth in neonates whose mothers received this drug during late pregnancy and/or labor: hypotonia, movement disorders including extrapyramidal disorders, clonic movements, central nervous system (CNS) depression, neonatal hypoxic conditions, or urinary retention. Animal studies have revealed reproductive toxicity (fetal malformations and abortions) occurring at doses substantially above the human therapeutic range. Additionally, doses of 10 mg/kg/day for 70 days reduced the concentration and viability of spermatocytes in male animals. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Hydroxyzine Breastfeeding Warnings

UK: Contraindicated US: This drug should not be given to nursing mothers. Excreted into human milk: Unknown Comments: Although there are no relevant data available, it is expected that this drug may be excreted into breast milk. The effects on the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Vistaril (hydroxyzine)." Pfizer US Pharmaceuticals, New York, NY.

References for breastfeeding information

  1. "Product Information. Vistaril (hydroxyzine)." Pfizer US Pharmaceuticals, New York, NY.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.